Bivalirudin

Cardio/Vascular

Evidence grade

AFDA-approved Rx (labeled use)

Cardiovascular · 0–5 · separate axis

PurposeAnticoagulation

MechanismDirect thrombin inhibitor (peptide)

EffectsDirect thrombin inhibitor (peptide)

DosingNo human dose established.

Bottom lineStrongest data when used for its labeled indication under clinician guidance.

Batches on filenone

No tested batches on file.

Read with10

Cautions & interactions

Bleeding risk; medical supervision

High bleeding risk with anticoagulants/antiplatelets/NSAIDs; hospital-only protocols.

CV 4 of 5 — Hospital cardiovascular use with strong clinical evidence for specific acute indications (not wellness).